Does Dysregulation Of The Indirect Pathway Contribute To The Pathophysiology Of Catatonia Through Neurotransmitter Imbalance? [PDF]
Seif P.
europepmc +1 more source
The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies-A Pilot Study. [PDF]
Oesch-Régeni B +4 more
europepmc +1 more source
Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophrenia. [PDF]
Fabiano N +5 more
europepmc +1 more source
Managing treatment-resistant schizophrenia following clozapine cessation: a case report of xanomeline-trospium and olanzapine combination therapy. [PDF]
Went NS +4 more
europepmc +1 more source
Is muscarinic receptor agonist effective and tolerant for schizophrenia? [PDF]
Guo X, Deng R, Lai J, Hu S.
europepmc +1 more source
Editorial: Mechanisms of cholinergic transmission in motivation and cognition. [PDF]
Francis TC, Klawonn AM.
europepmc +1 more source
Design, Synthesis, and Evaluation of a New Fluorescent Ligand for the M<sub>2</sub> Muscarinic Acetylcholine Receptor. [PDF]
Szabó R +12 more
europepmc +1 more source

